Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Review
|
Volume 14, Issue 18
|
pp. 7635–7649
A comprehensive review of pancreatic cancer and its therapeutic challenges
Back to article
Figure 1
(1 of 3)
−
100%
+
Figure 1.
Pro-pancreatic tumorigenic, aberrant genes/proteins and pathways.
Signals mediated by
mu-K-ras
,
mu-p53
and loss of
p16
INK
promote various uncontrollable cell growth, cell cycle progression and etc.
